Emerging <i>in vitro</i> models to study Merkel cell carcinoma pathobiology

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

Merkel cell carcinoma (MCC) is a rare but highly aggressive skin neoplasm, caused in approximately 80% of cases by the genomic integration of Merkel cell polyomavirus (MCPyV) and the expression of the viral small T antigen (sT) and large T antigen (LT) oncoproteins. Virus-negative tumors exhibit extensive UV-induced mutations. Despite such divergent molecular characteristics, the two etiologies share similar morphological and clinical features. The development of novel preclinical in vitro models that effectively recapitulate MCC pathobiology is essential for understanding the mechanisms of MCPyV infection and the cellular ancestry of MCC, a central topic of ongoing investigation and debate. This review provides a comprehensive overview of current two-dimensional (2D) and three-dimensional (3D) in vitro models developed to investigate the molecular and cellular mechanisms of MCC onset and progression. Continuous refinement of cell models that recapitulate MCC pathobiology is essential for advancing our understanding of the mechanisms of tumor onset and progression, thereby enhancing clinical applications for MCC patients.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.